Hypertension and Cardiovascular Risk Associated With Obstructive Sleep Apnea in Adult in Guadeloupe (French West Indies) (HTA-SAHOS)

Centre Hospitalier Universitaire de Pointe-a-Pitre

Status: Unknown

Conditions: Hypertension Arterial

Treatments: Other: Patient SAHOS sailed by the ventilation in PPC and not sailed; Other: Patient not SAHOS

Study type: Interventional

Funder types: Other

Identifiers

NCT03373357

RBM-PAP- 2007/19

Details and patient eligibility

About

The MAPA is the reference method to estimate the PA during the SAHOS. The MAPA can be recommended over 48 hours: indeed, the PA falls at the beginning of every apnea then increases gradually up to a pressif peak arising at the time of the ventilatoire resumption. These variations arise under the influence of 4 stimulus: the désaturation in O2, the rise of the PaCO2, the increase of the respiratory effort and the microawakening of the end of apnea who are at the origin of a sympathetic stimulation.

Consequently a better diagnostic approach of the HTA (confirmation of a resistant HTA, an identification of the masked HTA and the patients " not dipper " by the MAPA), the identification of the SAHOS, and a better coverage) of the associated cardiovascular risk factors are essential and establish a stake in public health.

To investigator's knowledge, no datum or study on the association HTA-SAHOS and its consequences was until then realized in the French overseas departments.

Full description

In Guadeloupe, data on the relationships between arterial hypertension and obstructive sleep apnea are unavailable. The aim of this study was: to assess the frequency of hypertension and non-dipper pattern evaluated by 48-hour ambulatory blood pressure monitoring in an adult population identified obstructive sleep apnea/non-obstructive sleep apnea during overnight polygraphy ; to determine the cardio-metabolic factors associated with obstructive sleep apnea.

Enrollment: 220 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient suspected of SAHOS;
• Patient or third-party responsible for receiving information on the study and who signed informed consent ;
• Patient age over 18 years; Patient living in Guadeloupe.

Exclusion criteria

• Patient non-affiliated to the social security scheme ;
• Patient with obstructive bronchopneumopathy, neuro-muscular pathology,
• central and mixed SAS, cardiac arrhythmia,
• systemic and chronic inflammatory syndrome ; -
• Pregnant and lactating patient ;
• patient in emergency.

Trial design

Primary purpose: Other

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

220 participants in 2 patient groups

Patient not SAHOS

Other group

Description:

The medical follow-up of patients no SAHOS will be assured by the investigators of the unity of cardiovascular explorations: phone consultation in 1 month, 3mois, then every 6 months, and an annual visit.

Treatment:

Other: Patient not SAHOS

Patient SAHOS sailed by the ventilation in PPC and not sailed

Other group

Description:

The patients who have a SAHOS sailed by the ventilation in PPC will be estimated and followed in 3 months then every 6 months by the investigators of the service of pneumology and the unity of cardiovascular explorations. The control of the material and its tolerance, the data supplied by the service providers (bodies of ventilation at home) will be estimated by the investigator of the service of pneumology. IDE the unity of cardiovascular explorations will plan and will realize a 2nd one MAPA after 3 months of ventilation in PPC.

Treatment:

Other: Patient SAHOS sailed by the ventilation in PPC and not sailed